{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T23:03:48Z","timestamp":1754262228581,"version":"3.41.2"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Arbutus Pharmaceuticals"},{"name":"Gilead"},{"name":"Merck"},{"DOI":"10.13039\/100019504","name":"Silverback Therapeutics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019504","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Liver Company"},{"name":"Yufan Biotechnologies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The management of invasive infections related to substance use disorder (SUD) needing parenteral antimicrobial therapy is challenging and may have poor treatment outcomes including nonadherence and lack of completion of parenteral antimicrobial therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this retrospective cohort of 201 patients with invasive infections related to SUD, we looked at frequency and determinants of unfavorable outcomes including nonadherence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seventy-nine percent of patients with SUD-related infection completed parenteral antibiotic therapy in skilled nursing facilities. A total of 21.5% of patient episodes had documentation of nonadherence. Nonadherence was higher in patients with active injection drug use (IDU) (28.5% versus 15% in non IDU; adjusted odds ratio [OR] 2.36; 95% confidence interval [CI], 1.1\u20135.5; P = .024), patients with active SUD in the prior year (24.5% vs 11%, P = .047), patients with use of more than 1 illicit substance (30.3% vs 17%, P = .031), as well as in people experiencing homelessness (32.8% vs 15.7% in stably housed, P = .005). In a multivariate model, nonadherence was significantly associated with IDU (OR, 2.38; 95% CI, 1.03\u20135.5) and homelessness (OR, 2.25; 95% CI, 1.01\u20134.8) Medication for opioid use disorder was prescribed at discharge in 68% of overall cohort and was not associated with improved outcomes for any of the above groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Nonadherence to parenteral antimicrobial therapy is high in the most vulnerable patients with unstable high-risk SUD and adverse social determinants of health.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofac633","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T04:26:36Z","timestamp":1670905596000},"source":"Crossref","is-referenced-by-count":5,"title":["Predictors of Nonadherence Among Patients With Infectious Complications of Substance Use Who Are Discharged on Parenteral Antimicrobial Therapy"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3440-0259","authenticated-orcid":false,"given":"Shivakumar","family":"Narayanan","sequence":"first","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6106-2799","authenticated-orcid":false,"given":"Patrick R","family":"Ching","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7127-3872","authenticated-orcid":false,"given":"Edward C","family":"Traver","sequence":"additional","affiliation":[{"name":"University of Maryland Medical Center , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivya","family":"George","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Amoroso","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7471-0812","authenticated-orcid":false,"given":"Shyam","family":"Kottilil","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"2023011808145435800_ofac633-B1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/jiz133","article-title":"Opioids and infectious diseases: a converging public health crisis","volume":"220","author":"Schwetz","year":"2019","journal-title":"J Infect Dis"},{"key":"2023011808145435800_ofac633-B2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff"},{"key":"2023011808145435800_ofac633-B3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.15585\/mmwr.mm6722a2","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among persons who inject drugs\u2014six sites, 2005\u20132016","volume":"67","author":"Jackson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023011808145435800_ofac633-B4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/M18-2124","article-title":"Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data","volume":"170","author":"Schranz","year":"2019","journal-title":"Ann Intern Med"},{"key":"2023011808145435800_ofac633-B5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.idc.2020.06.009","article-title":"Outpatient antimicrobial treatment for people who inject drugs","volume":"34","author":"Hurley","year":"2020","journal-title":"Infect Dis Clin North Am"},{"key":"2023011808145435800_ofac633-B6","doi-asserted-by":"crossref","first-page":"ofx102","DOI":"10.1093\/ofid\/ofx102","article-title":"Risk factors associated with outpatient parenteral antibiotic therapy program failure among intravenous drug users","volume":"4","author":"Buehrle","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2023011808145435800_ofac633-B7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/jhm.2597","article-title":"Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients","volume":"11","author":"Beieler","year":"2016","journal-title":"J Hosp Med"},{"key":"2023011808145435800_ofac633-B8","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy194","article-title":"Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature","volume":"5","author":"Suzuki","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2023011808145435800_ofac633-B9","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023011808145435800_ofac633-B10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2018.06.011","article-title":"In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs","volume":"92","author":"Fanucchi","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"2023011808145435800_ofac633-B11","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.1093\/infdis\/jiz516","article-title":"A comparison of medication for opioid use disorder treatment strategies for persons who inject drugs with invasive bacterial and fungal infections","volume":"222","author":"Marks","year":"2020","journal-title":"J Infect Dis"},{"author":"Wastila","key":"2023011808145435800_ofac633-B12","article-title":"The Maryland Statewide Epidemiological Outcomes Workgroup report on Epidemiological Profiles on Alcohol- and Drug- Related Hospitalizations based on Health Services and Cost Review Commission data 2016\u20132018"},{"key":"2023011808145435800_ofac633-B13","article-title":"Baltimore City Mayor's Office Baltimore City continuum of care's point-in-time count report"},{"key":"2023011808145435800_ofac633-B14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s11524-019-00379-9","article-title":"Homelessness, personal hygiene, and MRSA nasal colonization among persons who inject drugs","volume":"96","author":"Leibler","year":"2019","journal-title":"J Urban Health"},{"key":"2023011808145435800_ofac633-B15","doi-asserted-by":"crossref","first-page":"108797","DOI":"10.1016\/j.drugalcdep.2021.108797","article-title":"Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997\u20132017","volume":"225","author":"Hotton","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"2023011808145435800_ofac633-B16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.drugalcdep.2013.03.009","article-title":"The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD","volume":"132","author":"Linton","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"2023011808145435800_ofac633-B17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10096-018-03461-3","article-title":"Outcomes of patients with a history of injecting drug use and receipt of outpatient antimicrobial therapy","volume":"38","author":"O\u2019Callaghan","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2023011808145435800_ofac633-B18","first-page":"e1579","article-title":"Small-town America's despair: infected substance users needing outpatient parenteral therapy and risk stratification","volume":"9","author":"Camsari","year":"2017","journal-title":"Cureus"},{"key":"2023011808145435800_ofac633-B19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/cid\/ciy722","article-title":"A 9-point risk assessment for patients who inject drugs and require intravenous antibiotics: focusing inpatient resources on patients at greatest risk of ongoing drug use","volume":"68","author":"Eaton","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023011808145435800_ofac633-B20","doi-asserted-by":"crossref","first-page":"S408","DOI":"10.1093\/ofid\/ofab466.809","article-title":"611. No source control: low rates of medication for opioid use disorder in individuals hospitalized with infectious complications of injection opioid use at four academic medical centers","volume":"8","author":"Rosenthal","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2023011808145435800_ofac633-B21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jamainternmed.2019.5731","article-title":"Facilitating methadone use in hospitals and skilled nursing facilities","volume":"180","author":"Pytell","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023011808145435800_ofac633-B22","doi-asserted-by":"crossref","first-page":"ofy056","DOI":"10.1093\/ofid\/ofy056","article-title":"Outcomes according to discharge location for persons who inject drugs receiving outpatient parenteral antimicrobial therapy","volume":"5","author":"D\u2019Couto","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2023011808145435800_ofac633-B23","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/cid\/ciy632","article-title":"Many opportunities to record, diagnose, or treat injection drug-related infections are missed: a population-based cohort study of inpatient and emergency department settings","volume":"68","author":"Miller","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac633\/47805237\/ofac633.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/1\/ofac633\/48754287\/ofac633.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/1\/ofac633\/48754287\/ofac633.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T08:16:49Z","timestamp":1674029809000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac633\/6889557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac633","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,12,13]]},"article-number":"ofac633"}}